Empty IV Bags

Empty IV Bags Market Outlook

The global empty IV bags market is anticipated to reach approximately USD 2.3 billion by the year 2035, exhibiting a compound annual growth rate (CAGR) of around 7% during the forecast period from 2025 to 2035. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases requiring long-term IV therapy, the expanding healthcare infrastructure, and the heightened demand for safe and effective drug delivery systems. Furthermore, the rise in outpatient treatment options and the growing trend of home healthcare are also propelling the market forward. The shift towards minimally invasive procedures and the development of advanced materials for IV bags are expected to further stimulate market growth, ensuring that healthcare providers can effectively meet patients' needs while maintaining safety standards.

Growth Factor of the Market

One of the primary growth factors driving the empty IV bags market is the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases that necessitate continuous fluid therapy. Additionally, advancements in medical technology and an increase in the number of surgical procedures globally are also boosting the demand for IV bags. The growing geriatric population is another significant contributor, as older adults often require more medical interventions that involve IV therapy. Furthermore, the COVID-19 pandemic has highlighted the importance of efficient healthcare delivery systems, leading to an uptick in investments in healthcare facilities and the adoption of disposable medical supplies, including IV bags. As healthcare systems strive to enhance patient care and safety, the demand for high-quality empty IV bags is projected to rise.

Key Highlights of the Market

• The global empty IV bags market is projected to reach USD 2.3 billion by 2035.
• A CAGR of approximately 7% is anticipated during the forecast period of 2025-2035.
• Increasing prevalence of chronic diseases is a significant growth driver.
• Advancements in medical technology are boosting the adoption of IV therapy.
• Growing interest in home healthcare solutions is influencing market dynamics.

By Material Type

PVC:

Polyvinyl Chloride (PVC) is one of the most widely used materials in the production of empty IV bags due to its excellent flexibility, durability, and cost-effectiveness. PVC bags are capable of withstanding high temperatures and have good transparency, allowing healthcare providers to monitor fluid levels and conditions without opening the bag. However, the environmental impact of PVC production and disposal has led to a growing demand for alternative materials. Despite these concerns, PVC remains a popular choice in many healthcare settings because of its established performance and safety profile, particularly in hospitals and clinics where cost and functionality are paramount.

Polyolefin:

Polyolefin materials are increasingly gaining traction in the empty IV bags market due to their excellent chemical resistance and low leachability, ensuring that the integrity of the fluid is maintained. They are lightweight and offer improved flexibility compared to traditional PVC, making them easier to handle and transport. Additionally, polyolefin IV bags can be manufactured in a variety of sizes, catering to diverse healthcare applications. The growing focus on sustainability and the reduction of plastic waste has also led to an increase in polyolefin adoption, as they can be more easily recycled than their PVC counterparts, appealing to environmentally conscious healthcare facilities.

Polyethylene:

Polyethylene is known for its high clarity and low-density properties, making it an attractive option for empty IV bags. The material is flexible and provides a good barrier against moisture, ensuring that the medications remain stable and uncontaminated. As healthcare providers increasingly focus on patient safety and drug efficacy, polyethylene bags are becoming a preferred choice, particularly for drugs that are sensitive to light and other environmental factors. Moreover, manufacturers are exploring innovative designs and combinations of polyethylene with other materials to enhance performance and safety characteristics, further driving interest in this segment within the empty IV bags market.

Polypropylene:

Polypropylene is a type of thermoplastic polymer that offers high-temperature resistance, making it suitable for sterilization processes without compromising the bag's integrity. Its lightweight nature contributes to lower transportation costs, which is significant for healthcare facilities operating on tight budgets. Polypropylene bags also exhibit low leachability, making them an ideal choice for storing sensitive pharmaceutical products. As the demand for high-quality and reliable IV bags continues to grow, polypropylene is increasingly being recognized for its performance benefits, especially in specialized healthcare applications such as chemotherapy and parenteral nutrition.

Others:

This segment includes various alternative materials such as ethylene vinyl acetate (EVA) and thermoplastic elastomers (TPE), which are gaining attention in the empty IV bags market due to their unique properties. Materials like EVA provide enhanced flexibility and toughness, making them suitable for applications where durability is crucial. TPE is also being explored for its elasticity and ability to be produced with fewer environmental concerns compared to traditional plastics. As healthcare systems continue to evolve and seek out sustainable solutions, the demand for these alternative materials is expected to increase, driving innovations in the design and functionality of empty IV bags.

By Capacity

50 ml:

The 50 ml empty IV bags are typically utilized for applications that require precise dosages such as pediatric medicine and anesthetic administration. These bags are designed to provide a controlled delivery of fluids, ensuring that patients receive the exact volume needed for their treatment. Their compact size allows them to be easily integrated into a variety of medical devices and setups, making them a favorite for hospitals and clinics focusing on critical care. As the trend towards individualized medicine continues to grow, 50 ml IV bags are likely to see a sustained demand, particularly for outpatient and homecare settings.

100 ml:

100 ml empty IV bags strike a balance between compactness and versatility, making them suitable for a wide range of medical applications. They are commonly used for administering medications and fluids in both hospital and outpatient settings, providing healthcare providers with an efficient solution for fluid delivery. The versatility of these bags allows them to be employed across various departments, from surgery to oncology. The growing focus on outpatient care and minimally invasive procedures contributes to the demand for 100 ml IV bags, as they are ideal for short-term therapies and can be easily transported.

250 ml:

As one of the more commonly used capacities, 250 ml empty IV bags are widely utilized in various healthcare environments for administering larger volumes of fluids. These bags are particularly beneficial in critical care settings where patients may require significant fluid resuscitation. The design of 250 ml bags often incorporates features that facilitate easy handling and quick connections to IV lines, enhancing the efficiency of the healthcare providers during emergencies. With the rising incidence of surgical procedures and critical care cases, the demand for 250 ml IV bags is expected to remain strong, as they offer a practical solution for fluid management in hospitals and surgical centers.

500 ml:

500 ml empty IV bags are primarily used in scenarios that require substantial volume fluid administration, such as during surgeries or for patients undergoing extensive fluid therapy. Their larger capacity allows them to serve multiple doses or provide continuous infusion of fluids, which is essential in critical care situations. The design of 500 ml bags often includes features such as anti-freeze properties and reinforced seams to ensure reliability during use. As the global healthcare landscape shifts towards more aggressive management of chronic and acute conditions, the demand for 500 ml IV bags is anticipated to grow, particularly in emergency and trauma care environments.

Others:

This segment encompasses a variety of other capacities that cater to specific medical needs, such as 1 liter or specialized custom volumes. These bags are often employed for unique applications, including blood transfusions, IV nutrition, and large-volume parenteral solutions. The requirement for custom sizes is often driven by specific treatment protocols or individual patient needs, allowing healthcare providers to optimize fluid delivery based on the clinical scenario. As the emphasis on personalized healthcare increases, the demand for varied capacity empty IV bags is likely to expand, allowing for more tailored treatment approaches.

By End User

Hospitals:

Hospitals are one of the primary end-users of empty IV bags, accounting for a significant portion of the market due to their extensive use in various departments such as emergency, surgical, and intensive care units. The demand for IV bags in hospitals is driven by the need for efficient fluid and medication delivery systems that can cater to a wide range of patient conditions. Hospitals frequently adopt advanced IV bag technologies to enhance patient safety and improve treatment outcomes. As healthcare systems evolve and the number of inpatient procedures rises, hospitals are likely to continue being a major consumer of empty IV bags, necessitating a steady supply of various capacities and materials.

Clinics:

Clinics, including outpatient and specialized care facilities, are increasingly adopting empty IV bags for a variety of treatments, including hydration therapy and medication administration. The growth of outpatient services and the emphasis on providing high-quality care in community settings are propelling the demand for IV bags in clinics. Clinics often require smaller capacity options that are easy to handle and transport, making them an ideal market segment for products like 50 ml and 100 ml IV bags. As clinics continue to expand their services and adopt more advanced treatment modalities, the demand for reliable and high-quality empty IV bags is expected to increase significantly.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are emerging as a vital segment within the empty IV bags market, due to their focus on same-day surgical procedures that often require IV therapy for anesthesia and recovery. The use of empty IV bags in these centers facilitates quick and efficient drug delivery, allowing for faster patient turnover and enhanced surgical outcomes. Additionally, ASCs are increasingly adopting disposable medical supplies, including IV bags, to maintain high standards of hygiene and patient safety. As the trend towards outpatient surgical procedures continues to grow, the market for empty IV bags within ambulatory surgical centers is expected to see significant growth, aligning with industry shifts towards minimizing hospital stays.

Homecare Settings:

Homecare settings represent a rapidly growing segment of the empty IV bags market, driven by the increasing trend of outpatient care and the aging population requiring ongoing medical treatment at home. Empty IV bags provide a convenient solution for patients needing long-term infusion therapy, allowing them to receive care in the comfort of their homes. The demand for home healthcare solutions is further accelerated by advancements in medical technology that enable safe and effective drug administration outside clinical environments. As more healthcare providers and patients embrace homecare options, the need for empty IV bags designed for at-home use is projected to grow significantly, fostering innovation in product design and functionality.

Others:

This segment includes various specialized facilities such as rehabilitation centers and nursing homes where empty IV bags are utilized for fluid and medication administration. These facilities often cater to patients with chronic illnesses or recovery needs, requiring reliable and efficient IV solutions. The demand for empty IV bags in these settings is driven by the need for ongoing patient management and therapeutic interventions. As the healthcare landscape continues to prioritize patient-centered care, the focus on providing quality treatment options in diverse facilities is expected to enhance the demand for empty IV bags across various other end-user segments.

By Closure Type

Spike Cap:

Spike cap closure technology is widely utilized in empty IV bags due to its ability to facilitate easy access to the contents without compromising sterility. This type of closure allows healthcare professionals to quickly connect IV lines and access the fluid without the risk of contamination, making it an ideal choice for critical care environments where speed and efficiency are paramount. The spike cap design also minimizes the risk of fluid spillage, ensuring that medications are administered accurately and safely. As hospitals and clinics strive to enhance patient care while maintaining stringent safety standards, the demand for spike cap closure IV bags is expected to remain strong.

Twist-off Cap:

Twist-off caps offer a secure sealing mechanism for empty IV bags, providing a reliable barrier against contamination and environmental exposure. This closure type is often preferred for long-term storage of IV solutions, as it allows for easy opening and resealing while maintaining sterility. The twist-off design is intuitive for healthcare providers, enabling quick access to the bag's contents without the need for specialized training. As the focus on preventing healthcare-associated infections grows, the popularity of twist-off cap closures is expected to increase, particularly in settings where prolonged IV therapy is required.

Snap Cap:

Snap cap closures are gaining traction in the empty IV bags market due to their simple design and ease of use. They provide a reliable and secure seal that can be easily opened with a simple push, allowing healthcare providers to quickly access the contents of the bag. The snap cap design is particularly advantageous in emergency situations where time is of the essence, ensuring that fluids can be administered promptly. As healthcare systems focus on streamlining procedures and minimizing barriers to patient care, the demand for empty IV bags with snap cap closures is likely to grow.

Screw Cap:

Screw cap closures offer a robust sealing mechanism for empty IV bags, providing an added layer of security against spillage and contamination. This type of closure is often used for larger volume bags, where the risk of accidental opening is higher. The screw cap design allows for secure attachment to IV lines, minimizing the likelihood of leakage during transport or handling. As the emphasis on patient safety and the prevention of medication errors increases, the use of screw cap closure IV bags is anticipated to rise, particularly in high-volume healthcare settings.

Others:

This segment encompasses various niche closure types that cater to specific medical requirements and preferences. Innovative closure designs are being developed to enhance user experience and safety, addressing the evolving needs of healthcare providers. These may include features such as integrated filters or additional sealing mechanisms that enhance the protective capabilities of the bags. As the demand for specialized medical solutions continues to grow, the segment for alternative closure types is expected to expand, fostering further innovation within the empty IV bags market.

By Region

The North American empty IV bags market holds a dominant position, accounting for approximately 40% of the global market share in 2023. The region's well-established healthcare infrastructure, along with the high prevalence of chronic diseases and advanced medical technologies, contribute to this leading position. The focus on patient safety, coupled with stringent regulatory standards, drives the demand for high-quality empty IV bags in hospitals and healthcare facilities across the United States and Canada. Additionally, the rising trend of outpatient care and the expansion of home healthcare services are expected to further propel market growth in this region, with a projected CAGR of 6.5% over the next decade.

In Europe, the empty IV bags market is projected to grow steadily, driven by the increasing adoption of advanced medical technologies and the growing emphasis on improving patient outcomes. The European market is characterized by a diverse healthcare landscape, with significant contributions from countries such as Germany, France, and the United Kingdom. The changing demographics, along with the rising incidence of chronic diseases, are also fuelling the demand for effective drug delivery systems. As sustainability becomes a key focus for healthcare providers in Europe, the adoption of eco-friendly materials for IV bags is expected to gain traction, positively impacting market dynamics in the region.

Opportunities

The empty IV bags market presents numerous opportunities for growth, particularly in emerging markets where healthcare infrastructure is rapidly developing. As nations continue to invest in their healthcare systems, the demand for high-quality disposable medical supplies, including IV bags, is expected to increase significantly. Additionally, the rise in telemedicine and home healthcare solutions creates a favorable environment for the expansion of IV bag applications, enabling healthcare providers to deliver care directly to patients in their homes. Companies that focus on creating innovative and sustainable IV bag solutions can capitalize on this growing trend, positioning themselves as leaders in the market.

Moreover, advancements in materials science and manufacturing technologies open the door for the development of new and improved empty IV bags designed for specific medical applications. For example, the use of biodegradable materials and environmentally friendly designs can attract healthcare facilities focused on sustainability while ensuring compliance with regulatory standards. Additionally, partnerships with healthcare providers to develop customized IV bag solutions tailored to their specific needs can further enhance market opportunities. As the healthcare landscape evolves, companies that prioritize innovation and adaptability will be well-positioned to seize these opportunities and drive growth in the empty IV bags market.

Threats

Despite the promising outlook for the empty IV bags market, several threats could potentially hinder growth. One significant challenge is the increasing regulatory scrutiny and compliance requirements that manufacturers must adhere to, particularly in regions with stringent health and safety standards. The cost associated with meeting these regulations can strain smaller manufacturers and lead to increased prices for healthcare providers. Additionally, the presence of alternative drug delivery systems, such as prefilled syringes and infusion pumps, could pose a competitive threat to traditional empty IV bags, especially in specialized applications where efficiency and precision are critical.

Furthermore, there is growing concern regarding the environmental impact of plastic waste generated from disposable medical supplies, including IV bags. As healthcare organizations increasingly adopt sustainable practices and seek to reduce their carbon footprint, demand for single-use plastics may face negative backlash. Companies that fail to adapt to these new environmental standards could find themselves at a disadvantage in the market. Addressing these threats requires proactive strategies from manufacturers, including investment in research and development to create biodegradable and recyclable alternatives, as well as fostering open communication with regulatory bodies to ensure compliance without compromising quality or safety.

Competitor Outlook

• B. Braun Melsungen AG
• Fresenius Kabi AG
• Terumo Corporation
• BD (Becton, Dickinson and Company)
• Medline Industries, Inc.
• Smiths Medical
• ICU Medical, Inc.
• Hospira, Inc. (a subsidiary of Pfizer Inc.)
• Allergan plc
• Cardinal Health, Inc.
• Vygon S.A.
• Halyard Health, Inc.
• Ambu A/S
• Amgen Inc.
• West Pharmaceutical Services, Inc.

The competitive landscape of the empty IV bags market is characterized by the presence of numerous global and regional players, each vying for market share through innovation, quality, and strategic partnerships. Major companies are focusing on expanding their product portfolios and enhancing manufacturing capabilities to meet the evolving needs of healthcare providers. Furthermore, there is an increasing emphasis on research and development, particularly in the area of sustainable materials and advanced technologies that can offer improved patient outcomes. As the market becomes more crowded, companies are also investing in marketing and branding initiatives to differentiate their products and strengthen their market presence.

Companies like B. Braun Melsungen AG and Fresenius Kabi AG are recognized leaders in the empty IV bags market, with extensive distribution networks and a strong focus on quality and safety. These organizations are continuously striving to introduce innovative solutions to cater to the growing demands of healthcare providers while maintaining compliance with regulatory standards. Their commitment to sustainability is also evident, as they invest in developing eco-friendly products that align with the global shift towards reducing plastic waste in healthcare. Additionally, partnerships with hospitals and healthcare facilities help these companies build strong relationships and ensure their products remain central to patient care.

In addition, companies such as BD (Becton, Dickinson and Company) and Medline Industries, Inc., are leveraging their expertise in medical technologies and supply chain management to capture a sizable share of the empty IV bags market. By developing strategic alliances and collaborative initiatives with key healthcare providers, these firms aim to enhance their competitive edge and expand their reach. Moreover, their focus on incorporating advanced features, such as integrated safety mechanisms and user-friendly designs, positions them well to meet the needs of modern healthcare environments. As the market continues to evolve, these major players will likely play a pivotal role in shaping the future landscape of empty IV bags.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ambu A/S
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Vygon S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Allergan plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smiths Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 ICU Medical, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 B. Braun Melsungen AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cardinal Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 West Pharmaceutical Services, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hospira, Inc. (a subsidiary of Pfizer Inc.)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Empty IV Bags Market, By Capacity
    • 6.1.1 50 ml
    • 6.1.2 100 ml
    • 6.1.3 250 ml
    • 6.1.4 500 ml
    • 6.1.5 Others
  • 6.2 Empty IV Bags Market, By End User
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Ambulatory Surgical Centers
    • 6.2.4 Homecare Settings
    • 6.2.5 Others
  • 6.3 Empty IV Bags Market, By Closure Type
    • 6.3.1 Spike Cap
    • 6.3.2 Twist-off Cap
    • 6.3.3 Snap Cap
    • 6.3.4 Screw Cap
    • 6.3.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Empty IV Bags Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Empty IV Bags market is categorized based on

By Capacity

• 50 ml
• 100 ml
• 250 ml
• 500 ml
• Others

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By Closure Type

• Spike Cap
• Twist-off Cap
• Snap Cap
• Screw Cap
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• B. Braun Melsungen AG
• Fresenius Kabi AG
• Terumo Corporation
• BD (Becton, Dickinson and Company)
• Medline Industries, Inc.
• Smiths Medical
• ICU Medical, Inc.
• Hospira, Inc. (a subsidiary of Pfizer Inc.)
• Allergan plc
• Cardinal Health, Inc.
• Vygon S.A.
• Halyard Health, Inc.
• Ambu A/S
• Amgen Inc.
• West Pharmaceutical Services, Inc.